Inhibrx Inc
NASDAQ:INBX

Watchlist Manager
Inhibrx Inc Logo
Inhibrx Inc
NASDAQ:INBX
Watchlist
Price: 79.27 USD -1.17% Market Closed
Market Cap: 1.2B USD

Wall Street
Price Targets

INBX Price Targets Summary
Inhibrx Inc

There are no price targets for INBX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Inhibrx Inc Competitors:
Price Targets
600201
Jinyu Bio-Technology Co Ltd
40% Downside
ARMP
Armata Pharmaceuticals Inc
44% Upside
INSM
Insmed Inc
24% Upside
BONEX
Bonesupport Holding AB
114% Upside
CCCC
C4 Therapeutics Inc
460% Upside
TRDA
Entrada Therapeutics Inc
65% Upside
KALV
Kalvista Pharmaceuticals Inc
108% Upside
SYNACT
SynAct Pharma AB
15% Upside

Revenue
Forecast

Revenue Estimate
Inhibrx Inc

For the last 6 years the compound annual growth rate for Inhibrx Inc's revenue is -47%. The projected CAGR for the next 4 years is 372%.

-47%
Past Growth
372%
Estimated Growth
Estimates Accuracy
16%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Inhibrx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Inhibrx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INBX's stock price target?
Not Available

INBX doesn't have any price targets made by Wall Street professionals.

What is Inhibrx Inc's Revenue forecast?
Projected CAGR
372%

For the last 6 years the compound annual growth rate for Inhibrx Inc's revenue is -47%. The projected CAGR for the next 4 years is 372%.

Back to Top